AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 65 filers reported holding AVROBIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,359 | -80.3% | 3,111 | -68.7% | 0.00% | -100.0% |
| Q2 2021 | $88,287 | -20.6% | 9,931 | +13.3% | 0.00% | -50.0% |
| Q1 2021 | $111,215 | -19.7% | 8,764 | -11.8% | 0.00% | 0.0% |
| Q4 2020 | $138,494 | +7.1% | 9,935 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $129,354 | -25.4% | 9,935 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $173,366 | +43.8% | 9,935 | +28.2% | 0.00% | 0.0% |
| Q1 2020 | $120,543 | -2.8% | 7,747 | +25.7% | 0.00% | +50.0% |
| Q4 2019 | $124,021 | +42.6% | 6,161 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $86,993 | +298.1% | 6,161 | +358.4% | 0.00% | – |
| Q2 2019 | $21,853 | -88.5% | 1,344 | -63.3% | 0.00% | -100.0% |
| Q3 2018 | $189,740 | – | 3,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |